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Objectives: To examine gender differences along the care pathway to total hip replacement.
Methods: We conducted a population-based cross-sectional study of 26,046 individuals aged 35 years
and over in Avon and Somerset. Participants completed a questionnaire asking about care provision at
ﬁve milestones on the pathway to total hip replacement. Those reporting hip disease were invited to
a clinical examination. We estimated odds ratios (ORs) [95% conﬁdence intervals (CI)] for provision of
care to women compared with men.
Results: 3169 people reported hip pain, 2018 were invited for clinical examination, and 1405 attended
(69.6%). After adjustment for age and disease severity, women were less likely than men to have con-
sulted their general practitioner (OR 0.78, 95%-CI 0.61–1.00), as likely as men to have received drug
therapy for hip pain in the previous year (OR 0.96, 95%-CI 0.74–1.24), but less likely to have been referred
to specialist care (OR 0.53, 95%-CI 0.40–0.70), to have consulted an orthopaedic surgeon (OR 0.50, 95%-CI
0.32–0.78), or to be on a waiting list for total hip replacement (OR 0.41, 95%-CI 0.20–0.87). Differences
remained in the 746 people who had sought care from their general practitioner, and after adjustment for
willingness and ﬁtness for surgery.
Conclusions: There are gender inequalities in provision of care for hip disease in England, which are not
fully accounted for by gender differences in care seeking and treatment preferences. Differences in
referral to specialist care by general practitioners might unwittingly contribute to this inequity. Accurate
information about availability, beneﬁts and risks of hip replacement for providers and patients, and
continuing education to ensure that clinicians interpret and correct patients’ assumptions could help
reduce inequalities.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Gender differences in receipt of health care are well documented.
In the United Kingdom, women have been shown to be less likely
thanmen to receive exercise tolerance testing1, coronary angioplasty,
bypass grafting1,2, and cardiac rehabilitation after taking into
account disease severity3. Women with renal failure are also less
likely to be put on waiting lists for kidney transplantation4. These
examples have been researched because routine data sources show
lower rates of procedures in women. In contrast, when crude dataStephan Reichenbach, Insti-
ern, Finkenhubelweg 11, 3012
631-35-20.
ach).
Research Society International. Pushow that women are more likely thanmen to undergo a procedure,
as in the case of hip arthoplasty5,6, there is assumed to be no
inequality. However data from both Canada and the US suggest that
gender inequities exist in relation to the treatment of hip disease,
including hip replacement5,7.
To examine gender inequity in the provision of surgery, differ-
ences throughout the care pathway should be studied preferably in
a system inwhich access is not greatly inﬂuenced by unmet demand.
In England, this is more likely to be the case for hip replacement8,
than for knee replacement9: the estimated population requirement
for total hip replacement was only about 20% more than the number
of total hip replacements actually performed in 19958, compared
with a requirement for total knee replacement that was about 90%
more than the number of performed operations9. The objective of
this study was to examine gender differences in care provision for
hip disease at ﬁve stages along the care pathway: consultations withblished by Elsevier Ltd. All rights reserved.
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consultation with a specialist; and receipt of joint replacement,
taking into consideration the prevalence and severity of hip disease,
and willingness and ﬁtness to undergo surgery.
Methods
The Somerset and Avon Survey of Health (SASH) is a population-
based cross-sectional study in which 26,046 people selected from
40 general practices in the Southwest of England were sent a postal
questionnaire8,10. The study was reviewed and approved by the
relevant Local Research Ethics Committees and all participants
provided written informed consent. The survey included a question
to screen for hip pain, modiﬁed from the United States’ ﬁrst Health
and Nutrition Examination Survey11: ‘‘During the past twelve
months, have you had pain in or around either of your hips on most
days for one month or longer?’’
We invited respondents who reported hip pain to attend
a clinical examination. About 25% of participants were not invited
because they were certain that their hip pain was attributable
solely to disorders of the lower back8. Interviewers asked about ﬁve
milestones of care provision: whether participants (1) had ever
consulted their general practitioner for hip problems; (2) were
prescribed drug therapy for hip pain (including non-steroidal anti-
inﬂammatory drugs, opiates or acetaminophen) in the previous 12
months; (3) ever had been referred to specialist care for their hip
problems (rheumatologist or orthopaedic surgeon); (4) had con-
sulted an orthopaedic surgeon in the previous 12 months; and (5)
were on awaiting list for total hip replacement. All but the ﬁrst 163
participants were also asked whether they would accept surgery if
it were offered and about symptoms that might make them unﬁt
for surgery: participants who reported chest tightness, wheeze,
breathlessness, chest pain or palpitations many times a day or all
the timewere considered to have severe self-reported comorbidity.
We categorised occupation using the 1991 Standard Occupational
Classiﬁcation12: groups I, II and III (N) were classiﬁed as non-
manual, and groups III (M), IV and V as manual occupations.
We used the New Zealand priority criteria13 for major joint
replacement surgery to assess severity of hip disease. The New
Zealand Score, which ranges from 0 to 100, has subscores on pain
(40 points), disability (20 points), clinical ﬁndings (20 points),
multiple joint disease and ability to live independently (20 points).
Agreement of the developed criteria with overall clinical judge-
ment has been found to be excellent14. We assigned scores indi-
vidually for the left and right hip and used the worst score. There is
no agreed cut-off point for the New Zealand Score to represent
disease that warrants hip replacement surgery. We used two pre-
speciﬁed scores of 43 (moderately severe) and 55 (severe), for
which examples of the degree of pain and disability have been
published8.
Statistical analysis
We compared demographic and clinical characteristics of
female and male participants by calculating differences in propor-
tions, means or percentages (with 95% conﬁdence intervals, CI). We
used logistic regression models to compare the use of health
services and referral to specialist care for women and men with
available New Zealand Scores for the ﬁve milestones of care
provision. We estimated crude odds ratios (ORs, 95%-CI) and ORs
adjusted for age and disease severity. To determine whether
differences in care seeking or general practitioners’ referral
patterns explained differences in care provision, we restricted
analyses to participants who had consulted their general practi-
tioner for hip pain and to those who said they had been referred toa specialist. Then, we examined the effect of potential modiﬁers of
the decision to recommend surgery, adjusting additionally for
willingness and ﬁtness for surgery. In a post hoc sensitivity analysis,
we examined the inﬂuence of changing the deﬁnition of the ﬁnal
milestone: a combined endpoint of having undergone or awaiting
total hip replacement. Clustering within practices participating in
the SASH was previously shown to have negligible effects on the
magnitude of standard errors8, so our analyses did not account for
clustering.
We calculated the overall female to male ratio of participants
who reported being on a waiting list for total hip replacement
amongst those with data, using the direct method for age-
standardisation to the 1996 mid-year population of England. Data
collection in the SASH took place between November 30, 1993 and
February 29,1996. To determinewhether gender differences in care
provision for hip disease have changed over time, we calculated the
female tomale ratio for primary total hip replacement from 1991 to
2002 in patients admitted to NHS hospitals in England. We
included episodes that recorded one of three OPSC4 codes W37,
W38 or W39 in any of four procedure ﬁelds of the Hospital Episode
Statistics database (http://www.hesonline.nhs.uk/)6. All analyses
were performed in STATA 9.1 (Stata Corporation, College Station,
Texas, USA).
Results
Of 26,046 people selected, 22,204 responded to the screening
question for hip pain (85.2%). Of these, 269 women (2.2%) and 148
men (1.5%) reported a prior total hip replacement (age-adjusted OR
1.26, 95%-CI 1.02–1.55). 3169 reported hip pain (Fig. 1); of these, we
invited 2018 for further assessment. 371 participants could not be
invited due to resource limitations and 780 participants were not
invited because theywere certain that their hip painwas attributable
solely to disorders of the lower back8. Amongst those invited, 1405
(69.6%) attended and 1302 were assigned a New Zealand Score.
Women and men had similar response and attendance rates for
examination (Fig. 1). Characteristics of participants with New Zea-
land Scores assigned are presented in Table I.
The age-standardised female to male ratio for being on a waiting
list for total hip replacement for the 22,803 SASH participants with
available data was 1.33 (95%-CI 0.79–2.22). There was substantial
variation across age groups. Women tended to be less likely to be on
a waiting list for total hip replacement than men at ages below 65
years, but more likely above this age. For example, 0.8 per 1000
women and 5.4 per 1000 men were on a waiting list among 55–64
year olds (OR 0.15, 95%-CI 0.03–0.67). Conversely, 6.8 per 1000
women and 2.7 per 1000 men were on a waiting list among 65–74
year olds (OR 2.57, 95%-CI 0.94–7.03). When we adjusted for age in
logistic regression analysis, we found women and men in the overall
sample of SASH participants to be equally likely to be on awaiting list
(OR 1.02, 95%-CI 0.61–1.71). Figure 1 indicates that 17%ofwomen and
11% of men reported hip pain. After adjustment for the presence of
hip pain, women tended to be less likely thanmen to be on awaiting
list for total hip replacement (OR adjusted for age and hip pain 0.59,
95%-CI 0.34–1.01). Differences became more pronounced after
restricting of the analysis to those who had reported hip pain on the
screening questionnaire (age-adjusted OR 0.53, 95%-CI 0.31–0.92).
Figure 2 shows gender differences for the different milestones of
care provision for the 1302 participants who had attended clinical
examination and were assigned New Zealand Scores. After adjust-
ment for age and disease severity, womenwere less likely thanmen
to have consulted a general practitioner for their hip problems, as
likely as men to have been on drug therapy for their hip pain in the
previous year, but less likely to have been referred to specialist care,
to have consulted an orthopaedic surgeon in the previous year or to
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Fig. 1. Study ﬂow diagram.
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39 men (8.4%) had already undergone total hip replacement (OR
adjusted for age and severity 0.48, 95%-CI 0.30–0.77). A change in
the deﬁnition of the ﬁnal milestone of care provision to a combined
endpoint of having undergone or awaiting total hip replacement
yielded similar results (OR adjusted for age and severity 0.49, 95%-
CI 0.32–0.74).
Therewere 746 patients (468women)who had sought care from
their general practitioner. Amongst this group, gender differences
remained for referral to specialist care, consulting an orthopaedic
surgeon and awaiting total hip replacement (Table II). Restricting
the analysis to patients referred to specialist care (n¼ 290), we
found less pronounced gender differences in the probability of
consulting an orthopaedic surgeon (OR adjusted for age and severity
0.77, 95%-CI 0.46–1.28) and being placed on a waiting list
(OR adjusted for age and severity 0.60, 95%-CI 0.27–1.33).Women were less willing to undergo surgery (Table I): 493/749
of women (66%) vs 238/399 of men (60%) with available data were
reluctant to undergo surgery if it were offered (OR adjusted for age
and severity, 1.48, 95%-CI 1.12–1.95). Conversely, women tended to
be less likely to report severe comorbidity than men: 44/749 of
women (6%) vs 32/399 ofmen (8%) (OR adjusted for age and severity
0.67, 95%-CI 0.41–1.07). After adjusting for age, disease severity,
willingness and ﬁtness for surgery, gender differences remained for
referral to specialist care (OR 0.51, 95%-CI 0.38–0.69), consulting an
orthopaedic surgeon (OR 0.51, 95%-CI 0.32–0.82), and awaiting total
hip replacement (OR 0.53, 95%-CI 0.23–1.23).
Figure 3 shows that age-standardised rates of total hip replace-
ment in women and men in England increased between 1991 and
2002 but that female to male ratios did not change. The female to
male ratios of 1.39 in 1994 and 1.32 in 2002 found in Hospital
Episode Statisticswere compatiblewith the ratio of 1.33 for being on
Table I
Characteristics of participants with New Zealand Scores assigned, including poten-
tial modiﬁers of care provision
Characteristics Women
(n¼ 835)
Men (n¼ 467) Difference (95%-CI)
Age [years (SD)] 62.8
(12.9)
61.8 (11.6) 1.0 (0.4 to 2.4)
White ethnicity
[n/total (%)]
807/820
(98.4%)
455/460 (98.9%) 0.5% (1.8 to 0.8)
Manual occupation
[n (%)]
603/826
(73.0%)
315/466 (67.6%) 5.4% (0.2 to 10.6)
Married [n (%)] 500/821
(60.9%)
362/460 (78.7%) 17.8% (22.8 to 12.8)
New Zealand Score
[points (SD)]
26.6
(19.4)
24.8 (19.8) 1.8 (0.4 to 4.1)
Severe self-reported
comorbidity
[n/total (%)]
44/749
(5.9%)
32/399 (8.0%) 2.1% (5.2 to 1.0)
Unwilling to accept
surgery
[n/total (%)]
493/749
(65.8%)
238/399 (59.7%) 6.1% (0.3–12.1)
Data are presented separately for women and men as means with standard devia-
tions (SD) for continuous data and numbers and denominators with percentages for
binary data. Differences with 95% CI relate to between-gender differences in means
for continuous and in percentages for binary data. Note that denominators differ
because some data were missing for demographic variables and because self-
reported comorbidity and willingness to accept surgery were not ascertained in
the ﬁrst 154 out of a total of 1302 participants with New Zealand Scores assigned.
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ipants with available data reported above.
Discussion
In this population-based cross-sectional study, womenwere less
likely to be on a waiting list for total hip replacement. Womenwith
hip painwere as likely as men to be prescribed medication, but less
likely to be referred to specialist care by their general practitioner.
Gender disparities were not explained by differences in care
seeking, willingness to undergo, or ﬁtness for, surgery.
The strengths of this study are that it is population-based and
provides data on the complete pathway from reporting symptoms
through to being on awaiting list for surgery. The age-standardised
female to male ratio for hip replacement was the same in partici-
pants in our study as in England as a whole in 200215. Age-
standardised female to male ratios of total hip replacement inNumber (%)
Women Men Crude
Ever sought care from general 
practitioner 468 (56%) 278 (60%) 0.87 (0.69-1.09)
 On drug therapy in previous 
12 months 267 (32%) 146 (31%) 1.03 (0.81-1.32)
Ever referred to specialist care 158 (19%) 132 (28%) 0.59 (0.45-0.77)
Consulted orthopaedic 
surgeon in previous 12 months 45 (5%) 44 (9%) 0.55 (0.36-0.84)
Awaiting hip replacement 15 (2%) 17 (4%) 0.48 (0.24-0.98) 
Fig. 2. Care provision for hip disease in 835 women and 467 men with New Zealand Scores
care (left), crude ORs (middle) and ORs adjusted for age and disease severity (right) compar
care than men. As a measure for disease severity the New Zealand Score was used (range 0England remained constant between 1991 and 200215, so these
differences are unlikely to have changed over time. The limitations
of the SASH have been discussed previously8. Nonetheless, four
points deserve further attention. Firstly, we did not incorporate
radiographic information into the scores for assessing disease
severity13,14, because of the poor correlation with clinical disease
severity, uncertainty as to how to integrate X-ray data into the
score, and low attendance for X-ray examinations. Secondly, we did
not use body maps16 or other means to identify individuals with
chronic widespread pain. Thirdly, people who underwent a full
clinical examination might have had more severe disease than
thosewhowere not examined. Fourthly, the research process in our
study differed from true clinical decision making through interac-
tions between patients, general practitioners and orthopaedic
surgeons based on speciﬁc clinical and radiographic ﬁndings. Our
estimates of gender differences might therefore be biased in either
direction. However, we tried to minimise bias at all stages of the
study by using identical, standardised methods for women and
men, andwe consider it unlikely that biases can entirely explain the
consistency and magnitude of the observed disparities.
Our ﬁnding that women were about half as likely as men to
receive care for their hip disease shows that there is a need for total
hip replacement that has not been recognised by previous studies in
the United Kingdom8, and is not beingmet. Studies from the United
States of America and Canada have reported gender differences in
hip replacement5,7. The population-based study from Ontario,
Canada, byHawker et al. combined data on hip and knee disease and
also foundwomen less likely thanmen tohave seen a surgeon, be on
a waiting list, or to have undergone joint replacement5. Since
osteoarthritis of the hip and knee are distinct entities in terms of
predisposing factors, prevalence17, and care provision9, their anal-
ysis might have obscured important differences. In the SASH, indi-
viduals with hip disease were considerably more likely to receive
care than individuals with equally severe knee disease9. The age-
standardised female to male ratio for total hip replacement of 1.3
observed in our study and in England overall15 is similar to those
found in Canada (1.1)18 and in the United States (1.2)19. In the
Netherlands (2.6)20 and Sweden (1.6)20, the female to male ratios
are as we would expect when there is no gender inequality and
demand for hip replacement surgery is satisﬁed.
Gender differences do not necessarily mean that care is ineq-
uitable. If lower prevalence and milder disease accounted forOdds ratio (95% confidence interval)
Adjusted for age and disease severity
0.78 (0.61-1.00)
0.96 (0.74-1.24)
0.53 (0.40-0.70)
0.50 (0.32-0.78)
0.41 (0.20-0.87)
0.8 1 20.1 0.2 0.4
Women less likely
 to receive care
Women more likely 
to receive care
assigned. Shown are the number and percentage of women and men receiving health
ing women with men. An OR below one indicates that women are less likely to receive
–100).
Table II
Results of sensitivity analyses restricted to the 468 women and 278 men with New
Zealand Scores assigned who had sought care from their GP for their hip problems
Number (%) OR (95%-CI)
Women Men Crude Adjusted
On drug therapy in
previous 12 months
220 (47%) 127 (46%) 1.05
(0.78–1.42)
0.96
(0.71–1.31)
Ever referred to
specialist care
158 (34%) 131 (47%) 0.57
(0.42–0.77)
0.52
(0.38–0.72)
Consulted orthopaedic
surgeon in previous
12 months
45 (10%) 42 (15%) 0.60
(0.38–0.94)
0.56
(0.35–0.88)
Awaiting hip
replacement
15 (3%) 17 (6%) 0.51
(0.25–1.03)
0.41
(0.19–0.87)
Shown are the number and percentage ofwomen andmen receiving health care (left),
crude ORs (middle) and ORs adjusted for age and disease severity (right) comparing
women withmen. As a measure for disease severity the New Zealand Score was used
(range 0–100). An OR below one indicates that women are less likely to receive care
than men.
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uity. However, pain and disability associated with osteoarthritis of
the hip are likely to be more common and more severe in women
than men21. The poor correlation between clinical and radiographic
severity observed in our study8 makes it plausible that factors other
than physical damage, such as comorbid conditions, psychosocial
or socio-economic factors, could contribute to these differences.
Womenwith hip pain in our study tended to be less likely thanmen
to have visited their general practitioner and less willing to undergo
surgery. In contrast, Hawker et al. found that women were more
willing to have surgery5, but in both studies substantial gender
differences persisted after controlling for these factors.
Female gender is sometimes seen as a barrier to surgery22.
Qualitative studies have found that women tend to have higher
thresholds of disability before considering joint replacement, voice
more concerns about adverse outcomes of hip surgery, are more
likely to be concerned about being dependent, or not being able to
care for others during rehabilitation22, and might be less likely to
ask about possible treatment options23. In our study, the gender
difference in being referred to a specialist was greater than for being
put on a waiting list amongst patients who had consulted an
orthopaedic surgeon, although the smaller numbers in theseRate per 1000 in women
Rate per 1000 in men
Women to men rate ratio
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
94 96 98 0092 02
Fig. 3. Age-standardised annual rates of hip replacement in England 1991–2002 in
women and men and the corresponding rate ratio. A ratio above one indicates that
more women than men undergo hip replacement.analyses mean that the estimates are somewhat imprecise. Part of
the difference in referral ratesmight be due to general practitioners’
concern for involving patients in decisionmaking, taking their fears
into consideration, and interpreting their own perceptions of the
success of surgery24. Respecting their preferences might, however,
reinforce disparities if women’s perception of the risks involved is
misinformed, or if women are more likely than men to think that
they will not be eligible for surgery until they are extremely
disabled24. Further research, qualitative studies in particular, should
be carried out to investigate the ways in which doctors interpret
patients’ symptoms and fears, and how this inﬂuences their
management.
The results of our, and other studies5,7 suggest that both hori-
zontal gender inequity (higher threshold for referral of women for
specialist care)25,26 and vertical inequity (less access to surgery
despite more severe disease)25,26 in access to total hip replacement
exist. This underprovisionof care forhipdisease inwomen inEngland
is not fully accounted for by gender differences in care seeking and
treatment preferences. Differences in referral to specialist care by
general practitioners might unwittingly contribute to this inequity.
Borkhoff et al. had a male and female patient with identical radio-
logical severitywhowere trained to report identical complaints, both
visit general practitioners and orthopaedic surgeons and record
whether they were recommended total knee replacement. Women
were clearly discriminated against at the level of orthopaedic
surgeons (OR of 22 in favour of males), but to a lesser extent also at
the level of general practitioners (OR2)27. Accurate information about
the availability, beneﬁts and risks of hip replacement for providers
and patients, and continuing education to ensure that clinicians
interpret and correct patients’ assumptions could help improve
shared decision making and reduce inequalities.
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